Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
33%
Ph not_applicable
1
33%
Ph phase_3
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Withdrawn1
Not yet recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (33.3%)
Phase 31 (33.3%)
N/A1 (33.3%)

Trials by Status

withdrawn133%
not_yet_recruiting133%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable

The Effectiveness of Inhaled Salbutamol in the Management of Transient Tachypnea of the Newborn(TTN)

NCT07350421
withdrawnphase_3

Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma

NCT02127697
completedphase_1

A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics

NCT00673621

Clinical Trials (3)

Showing 3 of 3 trials
NCT07350421Not Applicable

The Effectiveness of Inhaled Salbutamol in the Management of Transient Tachypnea of the Newborn(TTN)

Not Yet Recruiting
NCT02127697Phase 3

Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma

Withdrawn
NCT00673621Phase 1

A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3